Product Images Oxcarbazepine

OXcarbazepine is a prescription-only drug with an NDC number of 70518-2377-01 and a Lot number that is not available. Its manufacturer is Breckenridge, headquartered in Boca Raton, FL 33487, and it was repackaged by RemedyRepack Inc., located in Indiana, PA 15701. For directions on use, refer to the package insert. The drug should be stored at a temperature between 20-26°C (63-77°F) with excursions allowed at 15-30°C (59-86°F) [See USP]. Keep this medication out of reach of children.*

Description: OXcarbazepine is a prescription drug with 100 HD2 quantity. It is only for medicinal use and requires an RX. Its NDC number is 70518-2377-02 with a LOT# which is not given. The manufacturer of the drug is Breckenridge located in Boca Raton, FL 33487. The drug packaging must be kept away from children, and usage directions are mentioned in the package insert. Further, it should be stored between 20-26°C (63-77°F); excursions can be permitted to 15-30°C (59-86°F) [See USP]. The drug is repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.466.8762.*

OXcarbazepine is a prescription drug packaged by RemedyRepack Inc. The medication is manufactured by Breckenridge in Boca Raton, Florida. The package includes a warning advising to keep the medication out of reach of children. The product should be stored at a temperature of 20-26°C (63-77°F), with excursions allowed to 15-30°C (59-86°F) according to USP standards. The package insert should be consulted for usage directions. The lot number and expiration date are not available.*

This is a description of a medication called OXcarbazepine. It comes in a quantity of 100 HD2, and it is a prescription-only medication. The NDC number for the medication is 70518-2377-00, and the manufacturer is Breckenridge, located in Boca Raton, FL 33487. The medication should be kept out of reach of children and stored at a temperature of 20-26°C (63-77°F). The directions for use of the medication can be found in the package insert. The medication was repackaged by RemedyRepack Inc., located in Indiana, PA 15701.*

This is a plot illustrating the exit rate with some statistical analysis. The 0.9 log-rank test showed a significant result with a p-value of 0.0001. The x-axis shows the time on trial from day 2 until day 11, and the y-axis shows the exit rate. The plot includes a group taking a placebo.*

The text presents statistical information about the seizure rate observed in a clinical study testing Oxcarbazepine vs. Placebo. The log-rank test reported a p-value of 0.046, indicating a statistically significant difference in the time to the first seizure between the two treatment groups. The chart shows the number of days between the first dose and the first seizure for patients in both groups.*

The text is describing a statistical analysis of a treatment group's "time to exit" in days. The group is divided into a "HIGH" and "LOW" category, and a log-rank test was performed with a resulting p-value of 0.0001. A chart is also included with values numbered from 10 to 130 along with the "Exitrate" value set to 0.*